Variant report
Variant | esv2829897 |
---|---|
Chromosome Location | chr8:51125957-51135544 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4873428 | chr8:51125957-51125958 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs116992082 | chr8:51125978-51125979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532133898 | chr8:51126019-51126020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550753650 | chr8:51126039-51126040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4873132 | chr8:51126059-51126060 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs530019176 | chr8:51126067-51126068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549093825 | chr8:51126070-51126071 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs567691781 | chr8:51126073-51126074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200448518 | chr8:51126119-51126120 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201725079 | chr8:51126122-51126123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs13278156 | chr8:51126123-51126124 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547158823 | chr8:51126136-51126137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs190523400 | chr8:51126159-51126160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs538811606 | chr8:51126192-51126193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557543602 | chr8:51126230-51126231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs569431889 | chr8:51126231-51126232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149569744 | chr8:51126274-51126275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs554261380 | chr8:51126275-51126276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375107600 | chr8:51126316-51126317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs539851815 | chr8:51126322-51126323 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10957826 | chr8:51126329-51126330 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs576550960 | chr8:51126379-51126380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371546666 | chr8:51126382-51126383 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs556227085 | chr8:51126390-51126391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113606288 | chr8:51126426-51126427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562737394 | chr8:51126430-51126431 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs200282012 | chr8:51126431-51126432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548198595 | chr8:51126484-51126485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529925295 | chr8:51126502-51126503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs568073753 | chr8:51126508-51126509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542156284 | chr8:51126553-51126554 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561260651 | chr8:51126586-51126587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192683624 | chr8:51126616-51126617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs199861090 | chr8:51126620-51126621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs547022191 | chr8:51126625-51126626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs576097045 | chr8:51126639-51126640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571733038 | chr8:51126647-51126648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs183791364 | chr8:51126664-51126665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs550871080 | chr8:51126735-51126736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs188391550 | chr8:51126757-51126758 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs536535956 | chr8:51126759-51126760 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201237496 | chr8:51126780-51126781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs199505467 | chr8:51126821-51126822 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs200544173 | chr8:51126825-51126826 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs554801306 | chr8:51126853-51126854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185555836 | chr8:51126931-51126932 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs533514861 | chr8:51127017-51127018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs4873133 | chr8:51127054-51127055 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs181253105 | chr8:51127078-51127079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4873134 | chr8:51127115-51127116 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:51124800-51126000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr8:51125000-51126000 | Enhancers | Osteobl | bone |
3 | chr8:51125800-51127200 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
4 | chr8:51127200-51127400 | ZNF genes & repeats | Ganglion Eminence derived primary cultured neurospheres | brain |
5 | chr8:51127400-51127600 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr8:51134400-51135200 | ZNF genes & repeats | Liver | Liver |